Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024
Compare Profit and Loss Results of Godavari Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
302.00
-189.00
-62.58%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
113.00
302.00
-189.00
-62.58%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-7.00
4.00
57.14%
Raw Materials Consumed
85.00
164.00
-79.00
-48.17%
Power & Fuel Cost
6.00
8.00
-2.00
-25.00%
Employee Cost
5.00
61.00
-56.00
-91.80%
Operating Expenses
3.00
10.00
-7.00
-70.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
12.00
-12.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
101.00
272.00
-171.00
-62.87%
Operating Profit (PBDIT) excl Other Income
11.00
30.00
-19.00
-63.33%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
12.00
32.00
-20.00
-62.50%
Interest
4.00
17.00
-13.00
-76.47%
Profit before Depriciation and Tax
8.00
15.00
-7.00
-46.67%
Depreciation
2.00
9.00
-7.00
-77.78%
Profit Before Taxation & Exceptional Items
5.00
5.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
5.00
0.00
0.00%
Provision for Tax
1.00
-2.00
3.00
150.00%
Profit After Tax
4.00
7.00
-3.00
-42.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
42.00
-22.00
-52.38%
Profit Available for appropriations
24.00
50.00
-26.00
-52.00%
Appropriations
24.00
50.00
-26.00
-52.00%
Equity Dividend (%)
0%
12%
-12.00
Earnings Per Share
5.82
4.89
0.93
19.02%
Profit And Loss - Net Sales
Net Sales 113.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024
Profit And Loss - Interest
Interest 4.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.38 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024
